These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 4249426)

  • 1. [Fibrinolytic homeostasis in pregnancy. I. Quantitative relations between pro- and anti-fibrinolytic factors. Clinical and experimental study].
    Giordano G
    Minerva Ginecol; 1969 Jul; 21(14):888-92. PubMed ID: 4249426
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fibrinolytic homeostasis in pregnancy. I. Quantitative relations between pro- and anti-fibrinolytic factors. Experimental and clinical contribution].
    Panazzolo A; Giambanco V; Pattarelli M; Scarpa F
    Haematol Lat; 1967; 10(4):409-22. PubMed ID: 4232988
    [No Abstract]   [Full Text] [Related]  

  • 3. [Considerations on the fibrinolytic enzymatic system and maternal serum and umbilical-cord fibrinogen in normal and gestosic pregnancy].
    Tanferna M; Giordano G; Giannice C
    Arch Sci Med (Torino); 1968 Nov; 125(11):629-35. PubMed ID: 4239824
    [No Abstract]   [Full Text] [Related]  

  • 4. [Fibrinolytic properties of "peritoneal" blood used for reinfusion in gynecologic practice].
    Tikhomirova NI; Khvatov VB
    Probl Gematol Pereliv Krovi; 1977 Feb; (2):38-42. PubMed ID: 141666
    [No Abstract]   [Full Text] [Related]  

  • 5. [On activators and inhibitors of fibrinolysis in the amniotic fluid and in extracts of the placenta, decidua and myometrium of interrupted and normally terminated pregnancies].
    Slunský R
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):236-43. PubMed ID: 4174664
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies of the components of the fibrinolytic system in the amniotic fluid].
    Giambanco V; Di Grigoli D
    Quad Clin Ostet Ginecol; 1968 Oct; 23(10):1193-205. PubMed ID: 4245051
    [No Abstract]   [Full Text] [Related]  

  • 7. [Activators and inhibitors of blood coagulation and fibrinolysis in the human placenta and myometrium].
    Uszyński M
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1971; 16():159-90. PubMed ID: 5004447
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased global fibrinolytic capacity as a clue for activated fibrinolysis in pre-eclampsia.
    Sucak GT; Acar K; Sucak A; Kirazli S; Haznedar R
    Blood Coagul Fibrinolysis; 2006 Jul; 17(5):347-52. PubMed ID: 16788310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The fibrinolytic system in the postoperative phase and its importance in normal and disturbed wound healing].
    Woziwodzki G
    Zentralbl Chir; 1967; 92(26a Pt 1):1086-90. PubMed ID: 4232849
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical significance of antithrombin III, plasminogen and alpha 2-plasmin inhibitor in perinatal period.
    Fuse Y; Fuse K
    Asia Oceania J Obstet Gynaecol; 1985 Mar; 11(1):121-5. PubMed ID: 3160323
    [No Abstract]   [Full Text] [Related]  

  • 11. Coagulation factors and components of the fibrinolytic system in lymph and blood in dogs.
    Leandoer L; Bergentz SE; Nilsson IM
    Thromb Diath Haemorrh; 1968 Mar; 19(1):129-35. PubMed ID: 5652223
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of angiotensin II on indices of the fibrinolysis system in experiments in vitro].
    Golubenkova NI
    Lab Delo; 1981; (12):720-2. PubMed ID: 6172641
    [No Abstract]   [Full Text] [Related]  

  • 13. [Activator and inhibitor of fibrinolysis in the genital organs of the rat in the course of pregnancy].
    Januszko T; Buluk K
    Acta Physiol Pol; 1966; 17(4):569-80. PubMed ID: 6007876
    [No Abstract]   [Full Text] [Related]  

  • 14. Measurement of the inhibitor of plasminogen activation in the euglobulin test.
    Januszko T; Buluk K; Uszyńska-Folejewska R; Uszyński M
    Pol Med J; 1966; 5(4):914-9. PubMed ID: 5964912
    [No Abstract]   [Full Text] [Related]  

  • 15. [Possibilities of the method of fibrin plates for determination of the activity of the blood fibrinolytic system components].
    Butorov VN; Bokarev IN
    Lab Delo; 1978; (5):271-3. PubMed ID: 79009
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasmatic and platelet anti-plasmins and anti-activators.
    Den Ottolander GJ; Leijnse B; Cremer-Elfrink HM
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):404-15. PubMed ID: 4232162
    [No Abstract]   [Full Text] [Related]  

  • 17. The significance of fibrinolysis in abortion.
    Soma H
    Zasshi Tokyo Ika Daigaku; 1970 Mar; 28(2):343-50. PubMed ID: 4260254
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiactivator (antikinase) activity of human plasma and its blocking by parachloromercuribenzoate and salicylate.
    Nanninga LB; Guest MM
    Thromb Diath Haemorrh; 1971 Dec; 26(3):541-56. PubMed ID: 4259444
    [No Abstract]   [Full Text] [Related]  

  • 19. The fibrinolytic system of plasma after electroshock.
    Hilden M; Lauritsen O
    Scand J Clin Lab Invest; 1971 Dec; 28(4):435-7. PubMed ID: 4258036
    [No Abstract]   [Full Text] [Related]  

  • 20. Separation and characterization of two fibrinolytic inhibitors from human placenta.
    Uszynski M; Abildgaard U
    Thromb Diath Haemorrh; 1971 Jun; 25(3):580-9. PubMed ID: 4998018
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.